Hello! I'm your financial news analysis assistant. This article about "Huimin Bao" (a type of medical insurance) reveals a profound and ongoing industry transformation: the product, which was once strongly promoted by the government and seen by the public as a supplement to medical insurance, is undergoing a significant shift from being administratively driven to being market-driven.
To help you understand this easily, I'll first summarize the key points and then break down the logic behind these changes in five sections, explaining it in plain language.
📝 Summary of Key Points
In simple terms, the sharp decline in the participation rate of Huimin Bao in two cities in Zhejiang is not due to a deterioration in the product itself, but rather because the two supports that kept the participation rate high—government funding and administrative requirements—have been removed.
In the past, the high participation rates in places like Zhejiang (sometimes exceeding 90%) were driven by local government subsidies, mandatory assessments, and the strong endorsement of the Medical Insurance Bureau. Now, with Zhejiang abolishing the participation rate assessment in 2024 and the National Financial Regulatory Administration (SFRA) requiring Huimin Bao to return to its commercial insurance nature, government subsidies have decreased, giving insurance companies more control over pricing.
This has led to a temporary drop in participation rates, but it is also a necessary step for Huimin Bao to mature and escape a vicious cycle where the more it pays out, the less people are willing to buy it. In the future, Huimin Bao will no longer be a mandatory benefit; instead, it will need to compete on its own merits to attract customers.
---
🔍 In-Depth Analysis: Five Dimensions of the Transformation
1. The Myth of Zhejiang’s High Participation Rates Has Crumbled: It’s Not About the Product, but the End of Free Lunch
Many people were alarmed by the 29.8% and 42.4% drops in participation rates in the two Zhejiang cities, thinking that Huimin Bao was on the decline. However, the high participation rates in Zhejiang were essentially a unique and unsustainable phenomenon.
- Previous Approach: In Zhejiang, Huimin Bao was seen as a political initiative for shared prosperity. The government not only funded insurance for vulnerable groups but also included participation rates in officials' performance evaluations. It was like forcing employees to use company-provided meal vouchers or directly giving them meal tickets—everyone naturally participated.
- Current Changes: Since 2024, Zhejiang no longer assesses participation rates, and government subsidies have stopped. The number of insurance policies funded by the government has significantly decreased.
- Reality: Even without these subsidies, the participation rate in these two cities remains around 30%, which is still higher than Beijing’s rate of about 24.5%. So, it’s not that Huimin Bao has failed; it has simply returned to a market-driven model. It’s like stopping the practice of giving out free gifts to attract new customers; only those who truly see the value of the product will continue to buy it.
2. The Medical Insurance Bureau Hasn’t Left, but Its Role Has Changed: From Nanny to Partner
There are rumors that the Medical Insurance Bureau is withdrawing from Huimin Bao, but this is a misunderstanding. The Bureau is still involved but has shifted from a controlling role to a more supportive one.
- Previous Role (Nanny Mode): The Medical Insurance Bureau was very detailed, requiring a payout rate of over 85%, and if this was not met, insurance companies had to make additional payments. This was a heavy burden on them, as commercial insurance relies on risk-based pricing.
- Current Role (Partner Mode): In economically developed areas like Beijing, Shanghai, Guangzhou, and Shenzhen, as well as Zhejiang, the Bureau still provides essential support, such as allowing payments from personal medical insurance accounts and providing data interfaces, but it is letting go of some control.
- Reason for the Change: The SFRA’s guidelines (Document No. 745) require Huimin Bao to be priced based on age and health conditions, similar to other commercial insurances. The Bureau realizes that forcing insurance companies to lose money will harm both the companies and the public. Therefore, it allows companies to offer different pricing options and adjust coverage to make the products more competitive.
3. Insurance Companies Are Taking Control: From Scapegoats to Drivers
For insurance companies, Huimin Bao was once a costly and unprofitable task. Now, with the change in policy, they can finally take control of the situation.
- Previous Challenges: The mandatory payout rate of 85%-90% meant companies lost money, drained their risk reserves, and affected their ratings. Many team leaders responsible for Huimin Bao were under constant pressure, and employee turnover was high.
- Current Opportunities: With the SFRA’s intervention, insurance companies have more autonomy. They can:
- Price Differentially: Charge younger and healthier people less, and more for older people with pre-existing conditions, which is more in line with commercial principles and helps manage risks.
- Adjust Benefits: For example, the "Huirong Bao" in Chengdu has not increased in price, but the reimbursement rates have been adjusted to control costs.
- Results: No longer forced to lose money, companies are motivated to improve products and services, which is beneficial for consumers in the long run.
4. The Debate Over “Secondary Payouts”: Government Will vs. Commercial Logic
The most contentious point in the article is the requirement for secondary payouts. If the payout rate does not meet the government’s 85% standard, insurance companies must make up the difference.
- Government’s Perspective: Huimin Bao is meant to be affordable and a supplement to medical insurance, so it should not be highly profitable but should provide maximum protection for the public.
- Insurance Companies’ Perspective: Commercial insurance is based on contracts, and payouts depend on risk. Forcing secondary payouts violates financial principles. If companies have to make up for these differences, they cannot effectively manage risks through reinsurance.
- Current Situation: In regions like Zhejiang, where the Medical Insurance Bureau is still influential, secondary payouts are required. However, in other regions, this practice has been suspended or canceled as the SFRA emphasizes that payout rates should not be predetermined.
- Impact: Canceling secondary payouts means insurance companies must bear their own profits and losses, allowing the market to determine the success of the products.
5. The Future of Group Insurance: A Lifesaver or a New Trap?
To address the problem of only sick people buying insurance, some suggest group insurance (e.g., companies buying insurance for their employees).
- Optimistic View (Scholars): Programs like “Suzhou Zhibao” mix healthy and unhealthy employees, diluting risks and potentially saving money. Companies can also deduct the cost from taxes, and employees can use their medical insurance cards, which sounds appealing.
- Pessimistic View (Industry Practitioners):
- Financial Constraints: Companies are struggling financially and are less willing to provide insurance for employees.
- Resistance to Mandatory Participation: Mandatory participation can lead to dissatisfaction, especially among young and healthy employees who prefer cheaper options.
- Sustainability: Both government and company-funded group insurance are often involuntary or semi-mandatory, lacking market vitality.
Conclusion: Group insurance may be a supplementary solution, but it is unlikely to become the mainstream. The future of Huimin Bao lies in its product quality.
💡 Advice for the Public
1. Don’t Panic: The decline in participation rates does not mean the product has worsened; it indicates a return to a more rational market approach. A 30% participation rate is still very high, indicating that most people still find it useful.
2. Watch for Price Changes: With marketization, different versions of Huimin Bao may emerge with varying prices. Younger and healthier people may see lower premiums, while older people or those with pre-existing conditions may see higher premiums or reduced coverage.
3. Read the Terms Carefully: Check for changes in deductibles, reimbursement rates, and the list of covered medications.
4. Make a Rational Choice: Huimin Bao remains a cost-effective option for covering major medical expenses. However, it should not replace commercial or basic medical insurance. If your budget allows and you are in good health, consider adding a high-value medical insurance for better protection.
In summary, Huimin Bao is transitioning from a government-driven program to a market-driven one. This transition may be uncomfortable, but it is essential for its long-term success.